Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Kingston · SciRah

Researcher profile · Semantic Scholar

B. Kingston

Share profile

B. Kingston — researcher profile on SciRah

h-index: 8
Works: 29
Citations: 633

Most-cited papers

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
N. Turner, B. Kingston, L. Kilburn, S. Kernaghan +24 more
2020The Lancet Oncology293 citations Open access
Semantic Scholar
Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
A. Pearson, P. Proszek, J. Pascual, C. Fribbens +22 more
2019Clinical Cancer Research114 citations Open access
Semantic Scholar
Genomic profile of advanced breast cancer in circulating tumour DNA
B. Kingston, R. Cutts, H. Bye, M. Beaney +20 more
2021Nature Communications92 citations Open access
Semantic Scholar
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer
B. Kingston, A. Pearson, M. T. Herrera-Abreu, Li-Xuan Sim +13 more
2023Cancer Discovery38 citations Open access
Semantic Scholar
Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations
B. Kingston, C. Bailleux, S. Delaloge, G. Schiavon +9 more
2019JCO Precision Oncology26 citations Open access
Semantic Scholar
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience
N. Battisti, B. Kingston, J. King, A. Denton +16 more
2019Breast Cancer Research and Treatment20 citations
Semantic Scholar
Abstract GS3-06: Results from the plasmaMATCH trial: A multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010)
N. Turner, B. Kingston, L. Kilburn, S. Kernaghan +21 more
2020General Session Abstracts11 citations
Semantic Scholar
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial
Iseult M. Browne, J. Pascual, R. Cutts, B. Kingston +15 more
2025Clinical Cancer Research8 citations Open access
Semantic Scholar
Fatigue in Breast Cancer Survivors
B. Kingston, M. Capelán
20167 citations
Semantic Scholar
Abstract GS3-07: The genomic landscape of breast cancer based on ctDNA analysis: Data from the plasmaMATCH trial
B. Kingston, H. Bye, M. Hubank, G. Walsh +13 more
2020General Session Abstracts6 citations
Semantic Scholar
ESR1 F404 mutations and acquired resistance to fulvestrant in the plasmaMATCH study.
B. Kingston, A. Pearson, M. T. Herrera-Abreu, R. Cutts +8 more
2022Journal of Clinical Oncology5 citations
Semantic Scholar
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA
B. Kingston, R. Cutts, H. Bye, M. Beaney +20 more
2021Nature Communications3 citations Open access
Semantic Scholar
Abstract PS5-02: Assessment of early ctDNA dynamics to predict efficacy of targeted therapies in metastatic breast cancer: Results from plasmaMATCH trial
J. Pascual, R. Cutts, B. Kingston, S. Hrebien +17 more
2021Poster Session Abstracts3 citations Open access
Semantic Scholar
Novel Treatments in Breast Cancer
B. Kingston, S. Johnston
20163 citations Open access
Semantic Scholar
Abstract P1-19-07: Results from plasmaMATCH trial treatment cohort B: A phase II trial of neratinib plus fulvestrant in ER positive breast cancer or neratinib alone in ER negative breast cancer in patients with aHER2mutation identified via ctDNA screening (CRUK/15/010)
A. Wardley, L. Kilburn, S. Kernaghan, I. Macpherson +13 more
20202 citations
Semantic Scholar
Abstract PS06-04: The prognostic and predictive impact of circulating tumour DNA (ctDNA) dynamics in patients with metastatic Triple Negative Breast Cancer (TNBC) on olaparib based therapy: Results from Cohort E of the PlasmaMATCH trial
Iseult M. Browne, J. Pascual, R. Cutts, B. Kingston +14 more
2024Cancer Research1 citations
Semantic Scholar
Directing Therapy with Circulating Tumor DNA Analysis in Advanced Breast Cancer: The PlasmaMATCH Trial
N. Turner, B. Kingston, L. Kilburn, S. Kernaghan +24 more
2020Social Science Research Network1 citations
Semantic Scholar
Abstract P1-19-04: Results from plasmaMATCH trial treatment cohort A: A phase II trial of extended-dose fulvestrant in patients with an ESR1 mutation identified via ctDNA screening (CRUK/15/010)
I. Macpherson, L. Kilburn, S. Kernaghan, A. Wardley +13 more
20201 citations
Semantic Scholar
Administration Reactions in Women with Breast Cancer Receiving Subcutaneous Trastuzumab
E. Grist, Nicola-Louise Ding, B. Kingston, S. Tattersfield +1 more
20161 citations
Semantic Scholar
Abstract P1-01-19: Predicting response to capivasertib in AKT1 mutant advanced breast cancer
Sarah Mearns, A. Pearson, R. Cutts, Heena Shah +18 more
2025Clinical Cancer Research0 citations
Semantic Scholar
99P Analysis of ctDNA in advanced breast cancer reveals polyclonal disease associated with adverse outcome
B. Kingston, R. Cutts, M. Beaney, Giselle Walsh-Crestani +16 more
20210 citations Open access
Semantic Scholar
Abstract P1-19-14: Results from plasmaMATCH trial treatment cohort D: A phase II trial of capivasertib in patients with an AKT activation basket mutation identified via ctDNA testing or tumour sequencing (CRUK/15/010)
R. Baird, L. Kilburn, S. Kernaghan, A. Wardley +13 more
20200 citations
Semantic Scholar
Abstract P1-19-11: Results from plasmaMATCH trial treatment cohort C: A phase II trial of capivasertib plus fulvestrant in ER positive breast cancer patients with anAKT1mutation identified via ctDNA screening (CRUK/15/010)
R. Roylance, L. Kilburn, S. Kernaghan, A. Wardley +13 more
20200 citations
Semantic Scholar
Results from plasmaMATCH: a multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer
A. Ring, B. Kingston, L. Kilburn, S. Kernaghan +21 more
20200 citations
Semantic Scholar
Acquired genetic events and NF1 mutations in advanced breast cancer
A. Pearson, P. Proszek, J. Pascual, C. Fribbens +22 more
20190 citations
Semantic Scholar
Abstract P6-18-23: Palbociclib and endocrine therapy in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: The UK compassionate access program experience
N. Battisti, B. Kingston, J. King, A. Denton +16 more
2019Poster Session Abstracts0 citations
Semantic Scholar
Exceptional Response to AKT inhibition in breast cancer patients with germline PTEN mutations
B. Kingston, A. Pearson, N. Turner
20190 citations
Semantic Scholar
Toxicity and efficacy of Palbociclib with endocrine therapy of physician’s choice in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: A single centre experience.
N. Battisti, B. Kingston, K. Mohammed, S. Johnston
20180 citations
Semantic Scholar
Toxicity and Efficacy of ≥4th Line Palbociclib with Endocrine Therapy of Physician’s Choice: a Single Centre Experience
B. Kingston, N. Charbouni, C. Doody, T. Irfan +2 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Turner×18
Invite
N. Turner — researcher profile on SciRah
L. Kilburn×18
Invite
L. Kilburn — researcher profile on SciRah
R. Roylance×18
Invite
R. Roylance — researcher profile on SciRah
A. Ring×16
Invite
A. Ring — researcher profile on SciRah

×15

Invite

I. Macpherson — researcher profile on SciRah

S. Kernaghan×13

Invite

S. Kernaghan — researcher profile on SciRah

Invite

R. Baird — researcher profile on SciRah

Invite

R. Cutts — researcher profile on SciRah

K. Wilkinson×13

Invite

K. Wilkinson — researcher profile on SciRah

Invite

J. Bliss — researcher profile on SciRah

Invite

A. Wardley — researcher profile on SciRah

Invite

H. Bye — researcher profile on SciRah